세계의 엑소좀 진단 및 치료 시장 : 유형별, 제품 및 서비스별, 소스별, 용도별, 최종 사용자별, 지역별

The Global Exosomes Diagnostic and Therapeutic Market is estimated to be valued at USD 78.2 Mn in 2024 and is expected to reach USD 256.1 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 18.5% from 2024 to 2031.

Figure. Exosomes Diagnostic and Therapeutic Market Share (%), By Region, 2024

The global exosomes diagnostic and therapeutic market has been witnessing significant growth in the recent years. Exosomes are nano-sized extracellular vesicles that act as carriers of biomolecules like proteins, lipids, and nucleic acids. They play an important role in cell-to-cell communication and immune response. The growing application of exosomes in diagnosis and treatment of various diseases like cancer, neurological disorders, and cardiovascular conditions is driving the growth of this market. Researchers and healthcare industry players are increasingly leveraging the potential of exosomes for developing minimally invasive liquid biopsies, drug delivery solutions, and regenerative therapies. Advancements in isolation and characterization techniques are further expanding the scope of research as well as clinical use of exosomes.

Market Dynamics:

The key drivers propelling the exosomes diagnostic and therapeutic market include growing demand for non-invasive diagnostic methods, increasing prevalence of target diseases, advantages of exosome-based therapies over conventional drugs, and technological advancements. However, high costs associated with isolation techniques and characterization tools, as well as lack of standardization are limiting the market growth. On the positive side, improved access and ongoing refinements are creating new opportunities. Emerging applications in anti-aging therapeutics, fertility management, and infection control also hold promise.

Key features of the study:

This report provides in-depth analysis of the global exosomes diagnostic and therapeutic market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global exosomes diagnostic and therapeutic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Evox Therapeutics Ltd, Exosome Diagnostics, Aethlon Medical, NanoSomix Inc, Thermo Fisher Scientific, Malvern Panalytical, System Biosciences LLC.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global exosomes diagnostic and therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global exosomes diagnostic and therapeutic market.

Detailed Segmentation:

• By Type Insights (Revenue, USD Mn, 2019 - 2031)
  • Exosome Diagnostics
  • Exosome Therapeutics
• By Product & Service Insights (Revenue, USD Mn, 2019 - 2031)
  • Instruments & Services
  • Kits & Reagents
• By Source Insights (Revenue, USD Mn, 2019 - 2031)
  • Stem Cells
  • Blood & Blood Plasma
  • Urine
  • Other Sources
• By Application Insights (Revenue, USD Mn, 2019 - 2031)
  • Cancer
  • Dermatological Diseases
  • Musculoskeletal Disorders
  • Cardiovascular Diseases
  • Others
• By End User Insights (Revenue, USD Mn, 2019 - 2031)
  • Hospitals & Diagnostic Centers
  • Clinics and Physician Settings
  • Academic and Research Institutions
  • Contract Research Organizations
  • Others
• By Regional Insights (Revenue, USD Mn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Thermo Fisher Scientific
  • NanoSomix
  • NX Pharmagen
  • Malvern Instruments
  • Capricor Therapeutic
  • Exosome Diagnostics
  • Exiqon A/S
  • System Biosciences
  • Exosome Sciences
  • Aegle Therapeutic
  • AMS Biotechnology
  • Miltenyi Biotec
  • Codiak BioSciences Inc.
  • Lonza Group (HansaBioMed Life Sciences Ltd.)
  • AcouSort AB
  • Aethlon Medical, Inc.
  • AGC Biologics
  • Anjarium Biosciences AG
  • Aruna Bio
  • Brexogen
  • Capricor Therapeutics
  • Cells for Cells
  • Ciloa
  • ConvEyXO

Table of Contents

1. RESEARCH OBJECTIVES AND ASSUMPTIONS

• Research Objectives
• Assumptions
• Abbreviations

2. MARKET PURVIEW

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Exosomes Diagnostic and Therapeutic Market, By Type
  • Global Exosomes Diagnostic and Therapeutic Market, By Product & Service
  • Global Exosomes Diagnostic and Therapeutic Market, By Source
  • Global Exosomes Diagnostic and Therapeutic Market, By Application
  • Global Exosomes Diagnostic and Therapeutic Market, By End User
  • Global Exosomes Diagnostic and Therapeutic Market, By Region

3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Exosomes Diagnostic and Therapeutic Market, By Type, 2024-2031, (USD Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Exosome Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Exosome Therapeutics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

5. Global Exosomes Diagnostic and Therapeutic Market, By Product & Service, 2024-2031, (USD Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Instruments & Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Kits & Reagents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Exosomes Diagnostic and Therapeutic Market, By Source, 2024-2031, (USD Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Stem Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Blood & Blood Plasma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Urine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Other Sources
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Exosomes Diagnostic and Therapeutic Market, By Application, 2024-2031, (USD Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Dermatological Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Musculoskeletal Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Cardiovascular Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Exosomes Diagnostic and Therapeutic Market, By End User, 2024-2031, (USD Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Hospitals & Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Clinics and Physician Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Academic and Research Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Contract Research Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

9. Global Exosomes Diagnostic and Therapeutic Market, By Region, 2019 - 2031, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Source, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Source, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Source, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Source, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Source, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Source, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

10. COMPETITIVE LANDSCAPE

• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• NanoSomix
• NX Pharmagen
• Malvern Instruments
• Capricor Therapeutic
• Exosome Diagnostics
• Exiqon A/S
• System Biosciences
• Exosome Sciences
• Aegle Therapeutic
• AMS Biotechnology
• Miltenyi Biotec
• Codiak BioSciences Inc.
• Lonza Group (HansaBioMed Life Sciences Ltd.)
• AcouSort AB
• Aethlon Medical, Inc.
• AGC Biologics
• Anjarium Biosciences AG
• Aruna Bio
• Brexogen
• Capricor Therapeutics
• Cells for Cells
• Ciloa
• ConvEyXO

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us